CDKN1B and rectal cancer: Kaplan–Meier analysis with the log-rank test based on 92 patients with rectal cancer indicated that the expression level of CDKN1B mRNA had no significant effect on OS (p > 0.05) (Supplementary Figure S5C) or DFS (p > 0.05) (Supplementary Figure S5D).